What this record means
The record shows that SARTELO is not a live or pending mark – the U.S. application was abandoned on September 16 2016 after the underlying International Registration under the Madrid Protocol was cancelled, and no revival petition was filed. The owner listed is Actavis Group PTC ehf., and the only listed class is 005 for “Pharmaceutical preparations and substances,” so a similar name used in the pharmaceutical field would be the closest area of concern. The record does not give the owner control over every possible use of the word SARTELO in other industries. Because the application was filed on the Principal Register and never moved to the Supplemental Register, the prosecution history simply reflects refusals and eventual abandonment rather than a supplemental‑register amendment. The latest meaningful event is the abandonment notice on November 1 2007 and the final status date in 2016; no opposition, cancellation, or court actions appear in the supplied history. I'd treat this as a moderate concern if you plan a pharmaceutical‑related brand, but the risk drops sharply for unrelated goods or services.
Informational only - not legal advice.